{"id":"https://genegraph.clinicalgenome.org/r/58ae5b9d-4850-4ed6-a6bf-573c51d98505v1.0","type":"EvidenceStrengthAssertion","dc:description":"RXYLT1 was first reported in relation to autosomal recessive Walker Warburg Syndrome (muscular dystrophy-dystroglycanopathy, congenital with brain and eye anomalies, type A, 10) in 2012 by Vuillaumier-Barrot. et al (PMID: 23217329). The condition is associated with certain brain and eye anomalies, congenital muscular dystrophy, and severe mental impairment. There is only one disease assertion for this gene, which is for autosomal recessive Walker Warburg Syndrome (OMIM: # 605862). 9 variants (missense, frameshift, nonsense) that have been reported in 7 probands in 4 publications (PMIDs: 23217329, 23519211, 33199158, 36007194) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be loss of function. This gene-disease relationship is also supported by experimental evidence (expression level evidence, functional alteration, protein interaction, cell culture model, rescue; PMIDs: 29477842, 27733679). In summary, there is definitive evidence supporting the relationship between RXYLT1 and autosomal recessive Walker Warburg Syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Brain Malformations GCEP on the meeting date [7/28/2023] (SOP Version  9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/58ae5b9d-4850-4ed6-a6bf-573c51d98505","GCISnapshot":"https://genegraph.clinicalgenome.org/r/31f6e2b9-8355-4631-8f6b-dadad24dabc4","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/31f6e2b9-8355-4631-8f6b-dadad24dabc4_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2023-07-28T15:30:23.626Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/31f6e2b9-8355-4631-8f6b-dadad24dabc4_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2023-07-28T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31f6e2b9-8355-4631-8f6b-dadad24dabc4_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c08dde0a-b575-443b-848b-001efa0a3f7f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ebb672db-7997-4915-bdbe-85d19460c46b","type":"EvidenceLine","dc:description":"Downgrading due to consanguinity (parents are second cousins).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ebb672db-7997-4915-bdbe-85d19460c46b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23519211","allele":{"id":"https://genegraph.clinicalgenome.org/r/6788ccb2-392a-476c-80f8-8da215d24836","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014254.3(RXYLT1):c.139del (p.Ala47ArgfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA143777"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/c08dde0a-b575-443b-848b-001efa0a3f7f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23519211","rdfs:label":"E: consanguineous, homozygous for p.Ala47Argfs*42","ageType":"AgeAtReport","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/6788ccb2-392a-476c-80f8-8da215d24836"},"detectionMethod":"Gene panel was done of RXYLT1 and SGK196, and patients did not carry mutations in any known WWS genes.","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":" Walker Warburg Syndrome; atrophy of pons and cerebellum, fronto-parietal pachygyria, enlarged ventricles, abnormal white matter","phenotypes":["obo:HP_0002119","obo:HP_0002500","obo:HP_0007360"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ebb672db-7997-4915-bdbe-85d19460c46b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/790c8e82-9498-4532-b0d0-beea0b989761_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76eff36e-7eac-427b-8f79-cb1ed647dcaf","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76eff36e-7eac-427b-8f79-cb1ed647dcaf_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"To determine the role of the variants in the condition, HAP1 cells deficient for TMEM5 were given cDNA coding for the variant from the proband. In contrast to the cells receiving the wild-type, the cells receiving the mutated TMEM5 were not able to restore Î±-DG (alpha dystroglycan) glycosylation or improve susceptibility to being infected with rVSV-GP-LASV (glycoprotein). This indicates the role of TMEM5 in a-DG glycosylation and therefore WWS.  ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/76eff36e-7eac-427b-8f79-cb1ed647dcaf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23519211","allele":{"id":"https://genegraph.clinicalgenome.org/r/a532e724-603e-48c8-a00c-076e81ea4028","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014254.3(RXYLT1):c.1018C>T (p.Arg340Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA143775"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/790c8e82-9498-4532-b0d0-beea0b989761","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23519211","rdfs:label":"Proband D:","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":22,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a532e724-603e-48c8-a00c-076e81ea4028"},"detectionMethod":"Gene panel was done of RXYLT1 and SGK196, and patients did not carry mutations in any known WWS genes. ","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Walker Warburg Syndrome; glycosylation issues","phenotypes":"obo:HP_0012345","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/76eff36e-7eac-427b-8f79-cb1ed647dcaf_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/50ed8d98-6cfa-47ae-a644-11922c146491_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e8dd5d8-32be-4e39-b24d-69f4ef024fa1","type":"EvidenceLine","dc:description":"Downgrading due to consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e8dd5d8-32be-4e39-b24d-69f4ef024fa1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23217329","allele":{"id":"https://genegraph.clinicalgenome.org/r/9e2786f2-dc32-4a83-ad4b-66ad7936caeb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014254.3(RXYLT1):c.279del (p.Gly94GlufsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130402"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/50ed8d98-6cfa-47ae-a644-11922c146491","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23217329","rdfs:label":"Proband B: p.Gly94Glufs*33","allele":{"id":"https://genegraph.clinicalgenome.org/r/9e2786f2-dc32-4a83-ad4b-66ad7936caeb"},"detectionMethod":"Probands were screened for mutations in POMT1, POMT2, POMGNT1, LARGE, FKTN, and FKRP, and none were found. Then, genome-wide linkage analysis was done. ","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Walker Warburg Syndrome; Cerebellar Dysplasia","phenotypes":"obo:HP_0007033","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/8e8dd5d8-32be-4e39-b24d-69f4ef024fa1_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/7f6ddb07-6eac-428b-b126-3b230ffccf99_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6df7c173-233e-4956-bdab-ad14b5be1447","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6df7c173-233e-4956-bdab-ad14b5be1447_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36007194","allele":{"id":"https://genegraph.clinicalgenome.org/r/f0a649e3-0c26-495d-ae1f-80dc5b15274a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014254.3(RXYLT1):c.147del (p.Ala50ArgfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580610996"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/41c67083-911d-4b52-8878-4d0a1c663034","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41c67083-911d-4b52-8878-4d0a1c663034_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36007194","allele":{"id":"https://genegraph.clinicalgenome.org/r/e410da0e-7fb1-4b68-9a83-fcf822f92cc2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014254.3(RXYLT1):c.947del (p.Lys316ArgfsTer19)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2041839955"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7f6ddb07-6eac-428b-b126-3b230ffccf99","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36007194","rdfs:label":"Compound heterozygous for p.Ala50Argfs*39 (c.147delC)","ageType":"AgeAtReport","ageUnit":"Months","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/e410da0e-7fb1-4b68-9a83-fcf822f92cc2"},{"id":"https://genegraph.clinicalgenome.org/r/f0a649e3-0c26-495d-ae1f-80dc5b15274a"}],"detectionMethod":"Panel testing and targeted variant sequencing were done. ","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Walker Warburg Syndrome; seizures soon after birth; exhibited persistent hyaloid arteries, retrolental membranes with total tractional retinal detachments, and microphthalmia; brother with same genotype had bilateral extensive peripheral avascular retina and persistent hyaloid arteries","phenotypes":["obo:HP_0007917","obo:HP_0000568","obo:HP_0001250"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/41c67083-911d-4b52-8878-4d0a1c663034_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/6df7c173-233e-4956-bdab-ad14b5be1447_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/4cffb54b-13d9-4f69-bd5e-b36f09226a2b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9eba64c-4bfb-4aac-8cea-77ba92b2c2b5","type":"EvidenceLine","dc:description":"Downgrading due to consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9eba64c-4bfb-4aac-8cea-77ba92b2c2b5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199158","allele":{"id":"https://genegraph.clinicalgenome.org/r/b5ba19ce-1c21-41cf-8e98-5e015c0a5b1a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014254.3(RXYLT1):c.390G>A (p.Trp130Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA385584590"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/4cffb54b-13d9-4f69-bd5e-b36f09226a2b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33199158","rdfs:label":"Male, neonate, Saudi in origin, p.Trp130Stop ","ageType":"AgeAtReport","ageUnit":"Months","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b5ba19ce-1c21-41cf-8e98-5e015c0a5b1a"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"WWS; Low-set ears; Depressed nasal bridge; last evaluated 3.5 months old; low birth weight (2.16 kg); severe hydrocephalus; subependymal heterotopia; left microphthalmia; right buphthalmia; macrocephaly","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d9eba64c-4bfb-4aac-8cea-77ba92b2c2b5_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/52d576b2-8bc8-4f22-a24e-846a6f3cc697_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0c2b3c6-f572-4f17-b5ba-1cd35ee6481b","type":"EvidenceLine","dc:description":"Functional evidence is counted in the experimental evidence section. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0c2b3c6-f572-4f17-b5ba-1cd35ee6481b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23217329","allele":{"id":"https://genegraph.clinicalgenome.org/r/e51a9bd8-aac4-4528-9d85-eb6ed723e822","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014254.3(RXYLT1):c.1019_1020delinsTT (p.Arg340Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130400"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2405fdc0-4e8b-45f8-b6be-df2c36f878a1","type":"EvidenceLine","dc:description":"The proband was a fetus, and another affected fetus from a different family had same frameshift mutation. The fetuses may have shared a common ancestral chromosomal segment for one allele, according to haplotype analysis. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2405fdc0-4e8b-45f8-b6be-df2c36f878a1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23217329","allele":{"id":"https://genegraph.clinicalgenome.org/r/50c96066-7c1b-4c32-81f4-3429926c7529","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014254.3(RXYLT1):c.1064_1091del (p.Asp355ValfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130401"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.75},{"id":"https://genegraph.clinicalgenome.org/r/52d576b2-8bc8-4f22-a24e-846a6f3cc697","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23217329","rdfs:label":"Proband C: compound heterozygous ","allele":[{"id":"https://genegraph.clinicalgenome.org/r/50c96066-7c1b-4c32-81f4-3429926c7529"},{"id":"https://genegraph.clinicalgenome.org/r/e51a9bd8-aac4-4528-9d85-eb6ed723e822"}],"detectionMethod":"Probands were screened for mutations in POMT1, POMT2, POMGNT1, LARGE, FKTN, and FKRP, and none were found. Then, genome-wide linkage analysis was done.","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Walker Warburg Syndrome; gonadal dysgenesis; major diffuse cerebellar dysplasia; minor diffuse retinal dysplasia","phenotypes":["obo:HP_0007033","obo:HP_0007973","obo:HP_0000133"],"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/2405fdc0-4e8b-45f8-b6be-df2c36f878a1_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a0c2b3c6-f572-4f17-b5ba-1cd35ee6481b_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.85},{"id":"https://genegraph.clinicalgenome.org/r/b8f996fb-0649-4290-bceb-7390475f8aaa_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8acdaf08-2af5-47ff-a409-5d5c5b219207","type":"EvidenceLine","dc:description":"Downgrading because this is a consanguineous family. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8acdaf08-2af5-47ff-a409-5d5c5b219207_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23217329","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a077ae6-6bbe-4e00-98b9-c57ca3a00c2e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014254.3(RXYLT1):c.795del (p.Arg266GlyfsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130398"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/b8f996fb-0649-4290-bceb-7390475f8aaa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23217329","rdfs:label":"Proband A: p.Arg266Glyfs*8 (c.795delG)","ageType":"AgeAtReport","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a077ae6-6bbe-4e00-98b9-c57ca3a00c2e"},"detectionMethod":"Probands were screened for mutations in POMT1, POMT2, POMGNT1, LARGE, FKTN, and FKRP, and none were found. Then, genome-wide linkage analysis was done. ","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Walker Warburg Syndrome; Neural tube defect; gonadal dysgenesis; visceral malformations; minor, diffuse cerebellar dysplasia. ","phenotypes":["obo:HP_0000133","obo:HP_0045005","obo:HP_0007033","obo:HP_0007973"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/8acdaf08-2af5-47ff-a409-5d5c5b219207_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/31f6e2b9-8355-4631-8f6b-dadad24dabc4_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31f6e2b9-8355-4631-8f6b-dadad24dabc4_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd62d353-6d87-4d57-bbc3-4921770d752b","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e9a606e-b247-4540-b571-fb1c7f0e15a1","type":"Finding","dc:description":"The expression of the two mutated proteins was only a bit reduced relative to the non-mutated protein, seen by Western blot studies. However, the incorporation of radioactivity into the FKRP product was not evident in any quantity in either mutated form. This shows that the two mutations inhibited TMEM5 xylosyltransferase activity. Figure A shows immunoprecipitation of the Myc-tagged proteins and Figure F shows the impact on function. Lack of appropriate xylosyltransferase activity is associated with abnormal glycosylation, which is strongly associated with Walker Warburg Syndrome. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27733679","rdfs:label":"Cell culture Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/19f56b79-99ea-42f4-8bec-a0a19b5dbd74","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b897638-36de-4c31-831c-f06af113544c","type":"Finding","dc:description":"Alpha dystroglycan glycosylation was restored in the sample rescued with wild-type RXYLT1. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27733679","rdfs:label":"Rescue in HAP1 cells","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/31f6e2b9-8355-4631-8f6b-dadad24dabc4_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88c9014d-aa8a-47e2-bea1-3f7715f365d6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae1a06d7-0805-4cdb-bae1-ad8cc2fee621","type":"Finding","dc:description":"When soluble TMEM5 reacted with FKRP, there was incorporation of radioactivity to the substrate acceptor notable. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27733679","rdfs:label":"Glycosylation; FKRP; FKTN","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/129a7835-6d00-4436-bb68-07f94856846d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7ba0491-a4c8-4bc4-be9a-09ea4e0f8b4d","type":"Finding","dc:description":"This article demonstrated, through immunofluorescence analysis in HEK293T cells, fukutin, FKRP, and TMEM5 assemble into a protein complex. This complex localizes to the Golgi apparatus. All three enzymes have their appropriate function when in the complex. Immunoprecipitation, western blot analysis, and enzyme assays demonstrated this. Cells were cultured in a high glucose medium and transfected.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29477842","rdfs:label":"FKTN FKRP","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fc85c89f-eec7-4ab1-9c17-805142a1a172","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b03cea58-07c9-4b8c-aae7-f625a9a53204","type":"Finding","dc:description":"Immunofluorescence was done. Triple staining with antibodies to FLAG, V5, and Myc showed colocalization of fukutin, FKRP, and TMEM5. Costaining with the Golgi marker GM130, which was done to each antibody, showed that the proteins localize to the Golgi, consistent with muscular dystrophy-dystroglycanopathy.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29477842","rdfs:label":"Golgi apparatus, co-localization","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Definitive","sequence":6669,"specifiedBy":"GeneValidityCriteria9","strengthScore":15.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/2sTB7WHiASM","type":"GeneValidityProposition","disease":"obo:MONDO_0018939","gene":"hgnc:13530","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_31f6e2b9-8355-4631-8f6b-dadad24dabc4-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}